Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, individually wrapped...
FDA Drug Recall #D-0962-2015 — Class III — March 24, 2015
Recall Summary
| Recall Number | D-0962-2015 |
| Classification | Class III — Low risk |
| Date Initiated | March 24, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Nomax Inc |
| Location | Saint Louis, MO |
| Product Type | Drugs |
| Quantity | 5,514 cartons |
Product Description
Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, individually wrapped strip (NDC 51801-004-01), barcode (01)00351801004019, packaged in 100-count strips per carton (NDC 51801-004-40, UPC 3 51801 00440 8), Nomax, Inc., St. Louis, MO 63123 USA.
Reason for Recall
Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of rose bengal present in the strips.
Distribution Pattern
Nationwide and Puerto Rico, Australia, Brazil, Canada, Chile, Colombia, Dominican Republic, Honduras, Iceland, Israel, Jamaica, Trinidad and Tobago, and St. Lucia
Lot / Code Information
Lot #: 8925, Exp 07/17; 8972, Exp 10/17; and 9195, Exp 04/18
Other Recalls from Nomax Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0462-2024 | Class II | GloStrips, Fluorescein Sodium Ophthalmic Strips... | Apr 19, 2024 |
| D-0465-2024 | Class II | FUL-GLO, Fluorescein Sodium Ophthalmic Strips U... | Apr 19, 2024 |
| D-0463-2024 | Class II | GloStrips, Fluorescein Sodium Ophthalmic Strips... | Apr 19, 2024 |
| D-0464-2024 | Class II | FUL-GLO, Fluorescein Sodium Sterile Ophthalmic ... | Apr 19, 2024 |
| D-0387-2021 | Class III | Dry Eye Test, Fluorescein Sodium, Ophthalmic St... | Apr 13, 2021 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.